CIK 0001770787
- Large accelerated filer
10x Genomics, Inc.
Sign in to watch- Ticker
- TXG
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 455614458
- Phone
- +1 925-401-7300
- Business address
- 6230 STONERIDGE MALL ROAD, PLEASANTON, CA, 94588
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $12,605,538
- in 10 filings, $6.3M under 10b5-1 plans
Net −$12,605,538. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 87 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-23 | Kosaraju Sridhar Director | Sale | −100 | $175.71 | $18K | 16,700 |
| 2021-03-23 | Kosaraju Sridhar Director | Sale | −200 | $178.07 | $36K | 16,500 |
| 2021-03-19 | Saxonov Serge Chief Executive Officer | Grant or award | +24,571 | 905,039 | ||
| 2021-03-19 | Saxonov Serge Chief Executive Officer | Grant or award · Stock Option (right to buy) | +61,428 | 61,428 | ||
| 2021-03-19 | McAnear Justin J. Chief Financial Officer | Grant or award | +8,935 | 39,292 | ||
| 2021-03-19 | McAnear Justin J. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +22,338 | 22,338 | ||
| 2021-03-19 | Hindson Benjamin J. Director | Grant or award | +11,169 | 47,805 | ||
| 2021-03-19 | Hindson Benjamin J. Director | Grant or award · Stock Option (right to buy) | +27,922 | 27,922 | ||
| 2021-03-19 | CRUTCHFIELD BRADFORD Chief Commercial Officer | Grant or award | +8,935 | 43,543 | ||
| 2021-03-19 | CRUTCHFIELD BRADFORD Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +22,338 | 22,338 | ||
| 2021-03-17 | STUELPNAGEL JOHN R Director | Sale | −700 | $164.88 | $115K | 450,291 |
| 2021-03-17 | STUELPNAGEL JOHN R Director | Sale | −800 | $165.80 | $133K | 449,491 |
| 2021-03-17 | STUELPNAGEL JOHN R Director | Sale | −601 | $166.80 | $100K | 448,890 |
| 2021-03-17 | STUELPNAGEL JOHN R Director | Sale | −920 | $167.98 | $155K | 447,970 |
| 2021-03-17 | STUELPNAGEL JOHN R Director | Sale | −1,100 | $169.27 | $186K | 446,870 |
| 2021-03-17 | STUELPNAGEL JOHN R Director | Sale | −813 | $170.09 | $138K | 446,057 |
| 2021-03-17 | STUELPNAGEL JOHN R Director | Sale | −500 | $171.27 | $86K | 445,557 |
| 2021-03-17 | STUELPNAGEL JOHN R Director | Sale | −1,266 | $172.29 | $218K | 444,291 |
| 2021-03-17 | STUELPNAGEL JOHN R Director | Sale | −400 | $173.28 | $69K | 443,891 |
| 2021-03-17 | STUELPNAGEL JOHN R Director | Sale | −400 | $174.50 | $70K | 443,491 |
Page 43 of 57 · 1,128 trades